Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
COPENHAGEN, Denmark— 8 February 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...
Search for Articles
Feb 8, 2018
Jan 29, 2018
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC Houston, TX, USA, January...
Nov 21, 2017
480 Biomedical’s Novel Technology Featured in Nature Materials
480 Biomedical develops new technology which imparts metal-like strength on bioresorbable polymers WATERTOWN, Mass., Nov. 21,...
Oct 10, 2017
Boston Scientific Announces Agreement to Acquire Apama Medical
Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments...
May 24, 2017
New Options in Wireless Remote Patient Monitoring
Interview with Michael Mazzini, MD Author(s): Interview by Jodie Elrod Issue Number: Volume 17 -...
May 15, 2017
Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke
Phase 3-ready program complements Biogen’s ongoing development efforts in stroke Biogen will pay a $120...